Abomics
@abomics.fi
Yksilöllinen lääkitys on tänään jokaisen lääkärin ja potilaan saatavilla. Sama lääke ja annos ei toimi kaikilla samalla tavalla. Geenit vaikuttavat siihen, miten elimistömme reagoi mm. masennus- ja särkylääkkeisiin sekä sydän- ja verisuonisairauksien lääkkeisiin. Abomics tarjoaa yhteistyössä laboratorioiden kanssa verinäytteeseen perustuvan farmakogeneettisen testin, josta lääkäri saa lausunnon lääkehoidon suunnittelun tueksi. Farmakogeneettinen testi Miten testiin? Lääkäreille For
Abomics's Company Logos
Abomics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0073B4
Deep Cerulean
0, 115, 180
202, 100, 35
100, 36, 0, 29
#639FDB
Havelock Blue
99, 159, 219
210, 62, 62
55, 27, 0, 14
#B70656
Lipstick
183, 6, 86
333, 94, 37
0, 97, 53, 28
About Abomics
Abomics is a Finnish expert company that provides tools to support physicians' decision-making. They aim to promote the application of medical research data in patient care to ensure safe and effective medication. Abomics offers a pharmacogenetic test in collaboration with laboratories, which is based on a blood sample.
This test provides doctors with a report to support medication planning. Through pharmacogenetic testing, Abomics can anticipate the response to medication based on an individual's genetic makeup, allowing for more efficient, safer, and personalized treatment options. Additionally, the test helps reduce the risk of adverse effects, speeds up the determination of appropriate medication, and supports treatment decisions throughout a patient's lifetime.
Abomics, together with its subsidiary Multirec, offers up-to-date medical databases, including medication indications, interactions, and pharmacogenetic information, which are accessible to physicians through patient information systems. This ensures that doctors have the necessary information to make informed medication decisions. Abomics is committed to improving patient outcomes by utilizing genomic information in medication management
